Lodestar Investment Counsel’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$20.2M Buy
109,359
+1,487
+1% +$266K 2.07% 16
2019
Q1
$20.5M Buy
107,872
+455
+0.4% +$86.9K 2.19% 16
2018
Q4
$20.9M Buy
107,417
+5,182
+5% +$1.01M 2.55% 11
2018
Q3
$21.2M Sell
102,235
-1,410
-1% -$278K 2.29% 13
2018
Q2
$19.1M Buy
103,645
+1,310
+1% +$232K 2.21% 13
2018
Q1
$17.4M Buy
102,335
+2,477
+2% +$455K 2.03% 15
2017
Q4
$17.4M Sell
99,858
-170
-0.2% -$30.1K 2% 16
2017
Q3
$18.6M Buy
100,028
+467
+0.5% +$82.7K 2.29% 13
2017
Q2
$17.1M Buy
99,561
+1,676
+2% +$273K 2.19% 12
2017
Q1
$16.1M Buy
97,885
+2,386
+2% +$396K 2.09% 15
2016
Q4
$14M Buy
95,499
+1,199
+1% +$180K 1.89% 16
2016
Q3
$15.7M Buy
94,300
+1,837
+2% +$311K 2.16% 15
2016
Q2
$14.1M Buy
92,463
+6,841
+8% +$1.06M 2% 16
2016
Q1
$12.8M Buy
85,622
+79,873
+1,389% +$11.9M 1.85% 18
2015
Q4
$933K Buy
+5,749
New +$904K 0.15% 74
2015
Q3
Sell
-1,368
Closed -$210K 141
2015
Q2
$210K Buy
1,368
+61
+5% +$9.77K 0.03% 145
2015
Q1
$209K Buy
+1,307
New +$206K 0.03% 147

Other funds holding AMGN

Lodestar Investment Counsel's AMGN Position: Q2 2019 in Review

Lodestar Investment Counsel increased its Amgen (AMGN) stake by 1.4% in Q2 2019, buying an estimated $266K and bringing the position to 109,359 shares worth $20.2M. The position accounts for 2.07% of the portfolio, ranked #16.

Lodestar Investment Counsel first reported a position in AMGN in Q1 2015 and has held it in 17 quarters since. The position peaked at $21.2M in Q3 2018. 1,865 funds tracked by Wall St. Rank hold AMGN as of Q2 2019.

  • Lodestar Investment Counsel held 109,359 shares of Amgen worth $20.2M as of Q2 2019.
  • Lodestar Investment Counsel bought 1,487 Amgen shares in Q2 2019, an estimated $266K.
  • Amgen made up 2.07% of Lodestar Investment Counsel's portfolio in Q2 2019, its #16 holding.
  • Lodestar Investment Counsel first reported a position in Amgen in Q1 2015 and has held it in 17 quarters since.
  • Lodestar Investment Counsel's Amgen position peaked at $21.2M in Q3 2018.
  • 1,865 funds tracked by Wall St. Rank held Amgen as of Q2 2019.

Based on Lodestar Investment Counsel's 13F filing for Q2 2019, filed 10 Jul 2019.